Insiders who reported open-market trades in the last 12 months at the companies George J. Morrow files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Kevin Charles Gorman - $37.82M in NBIX purchases and sales in the last 12 months
Julie Cooke - $5.77M in NBIX purchases and sales in the last 12 months
Kyle Gano - $4.87M in NBIX purchases and sales in the last 12 months
Stephen A. Sherwin - $4.13M in NBIX purchases and sales in the last 12 months
Ingrid Delaet - $3.75M in NBIX purchases and sales in the last 12 months
Darin Lippoldt - $3.50M in NBIX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
George J. Morrow is a corporate insider, tracked as Director of NEUROCRINE BIOSCIENCES INC (NBIX). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did George J. Morrow last file a Form 4?
The most recent primary Form 4 on record is dated 29 May 2026, one of 6 filings going back to 2025.
Has George J. Morrow been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($2.15M) across all tracked filings.
George J. Morrow is Director of NEUROCRINE BIOSCIENCES INC (NBIX). 6 SEC Form 4 filings on record going back to 2025, most recently on 29 May 2026. Most recent open-market trade: sold $2.15M of NBIX on 26 November 2025. Lifetime open-market sales: $2.15M.
Recent transactions
6
The latest 6 SEC Form 4 transactions reported by George J. Morrow.
InsiderAlpha's records for George J. Morrow go back to 2025: 6 primary Form 4 filings, an average of 3.0 per year. 3 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
